BACKGROUND: Sepsis is associated with increased morbidity, mortality, and costs of care. Although several therapies improve outcomes in patients with sepsis, rigorously developed measures to evaluate quality of sepsis care in the intensive care unit (ICU) are lacking. METHODS: To select an initial set of candidate measures, in 2003-2004 an interdisciplinary panel reviewed the literature and used a modified nominal group technique to identify interventions that improve outcomes of patients with sepsis in the ICU. Design specifications or explicit definitions for each candidate measure were developed. RESULTS: Ten potential measures were identified: vancomycin administration, time to vancomycin initiation, broad-spectrum antibiotic administration, time to broad-spectrum antibiotic initiation, blood culture collection, steroid administration, corticotropin stimulation test administration, activated protein C eligibility assessment, activated protein C administration, and vancomycin discontinuation. DISCUSSION: The identification of potential measures of quality of care for patients with sepsis can help caregivers to focus on evidence-based interventions that improve mortality and to evaluate their current performance. Further work is needed to evaluate the feasibility and validity of the measures.
BACKGROUND:Sepsis is associated with increased morbidity, mortality, and costs of care. Although several therapies improve outcomes in patients with sepsis, rigorously developed measures to evaluate quality of sepsis care in the intensive care unit (ICU) are lacking. METHODS: To select an initial set of candidate measures, in 2003-2004 an interdisciplinary panel reviewed the literature and used a modified nominal group technique to identify interventions that improve outcomes of patients with sepsis in the ICU. Design specifications or explicit definitions for each candidate measure were developed. RESULTS: Ten potential measures were identified: vancomycin administration, time to vancomycin initiation, broad-spectrum antibiotic administration, time to broad-spectrum antibiotic initiation, blood culture collection, steroid administration, corticotropin stimulation test administration, activated protein C eligibility assessment, activated protein C administration, and vancomycin discontinuation. DISCUSSION: The identification of potential measures of quality of care for patients with sepsis can help caregivers to focus on evidence-based interventions that improve mortality and to evaluate their current performance. Further work is needed to evaluate the feasibility and validity of the measures.
Authors: R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno Journal: Intensive Care Med Date: 2013-01-30 Impact factor: 17.440
Authors: Laura E White; Heitham T Hassoun; Azra Bihorac; Laura J Moore; R Matt Sailors; Bruce A McKinley; Alicia Valdivia; Frederick A Moore Journal: J Trauma Acute Care Surg Date: 2013-09 Impact factor: 3.313
Authors: Sabine N van der Veer; Maartje L G de Vos; Kitty J Jager; Peter H J van der Voort; Niels Peek; Gert P Westert; Wilco C Graafmans; Nicolette F de Keizer Journal: Implement Sci Date: 2011-10-24 Impact factor: 7.327
Authors: Caroline M A van den Bosch; Marlies E J L Hulscher; Stephanie Natsch; Inge C Gyssens; Jan M Prins; Suzanne E Geerlings Journal: BMC Infect Dis Date: 2014-06-20 Impact factor: 3.090
Authors: Bruno Adler Maccagnan Pinheiro Besen; Thiago Gomes Romano; Antonio Paulo Nassar; Leandro Utino Taniguchi; Luciano Cesar Pontes Azevedo; Pedro Vitale Mendes; Fernando Godinho Zampieri; Marcelo Park Journal: Ann Intensive Care Date: 2016-11-02 Impact factor: 6.925
Authors: Marlot C Kallen; Marie-Jose Roos-Blom; Dave A Dongelmans; Jeroen A Schouten; Wouter T Gude; Evert de Jonge; Jan M Prins; Nicolette F de Keizer Journal: PLoS One Date: 2018-11-29 Impact factor: 3.240
Authors: André Karch; Roland P Schmitz; Florian Rißner; Stefanie Castell; Sandra Töpel; Matthias Jakob; Frank M Brunkhorst; Rafael T Mikolajczyk Journal: BMJ Open Date: 2015-12-15 Impact factor: 2.692